CD14 is a co-receptor involved in the recognition of Gram-negative and Gram-positive bacteria, the latter known to cause dental caries. The aim of this study was to determine whether soluble CD14 (sCD14) in saliva was associated with caries activity and the collection method from the saliva. The study included 55 participants aged 20 to 40 years, 30 with dental caries and 25 caries-free controls. We collected 110 saliva samples in total, 55 of resting saliva and 55 of mechanically stimulated saliva. Median levels of sCD14, measured with a matrix-matched enzyme-linked immunosorbent assay (ELISA), were higher in the caries-active than in the caries-free group in either resting (203.3 vs.167.9 ng mL ; P<0.01). Hyposalivation was observed only in the caries-active group (10 and 13 % in stimulated and resting saliva, respectively). Higher salivary sCD14 levels and secretion rates were clearly associated with dental caries and resting saliva. Future studies should focus on the clinical utility of salivary sCD14 as a potential biomarker and predictor of future caries events.
Dental caries is the localised destruction of susceptible dental hard tissue caused by complex interactions between cariogenic bacteria, fermentable carbohydrates, and host factors (1, 2) . Common virulence factors among the Gramnegative bacteria are endotoxins (whose biologically active components are lipopolysaccharides, LPS) and among the Gram-positive bacteria it is the lipoteichoic acid (3, 4) . Both LPS and lipoteichoic acid bind to the CD14 co-receptor, which is a 55-kDa glycoprotein (5) . One of the CD14 functions is to neutralise LPS and other microbial constituents (peptidoglycans, lipoteichoic acids) and transfer LPS to the transmembrane toll-like receptors (TLRs) (6, 7) . Depending on the localisation, the CD14 receptor exists in two forms. The membrane bound CD14 (mCD14) is expressed on the surface of macrophage-like cells (monocyte, macrophage), activated neutrophils, and numerous non-myeloid cells including gingival fibroblasts (5, 6, 8) . The soluble form (sCD14), spontaneously released by these cells, circulates in the serum in high amounts (2-4 µg mL -1 ) and interacts with the LPS-binding protein (LBP) (9) . The LPS/LBP/CD14 ternary complex interacts with TLRs, which leads to cell activation (10) . Gingival epithelial cells, which are the first to encounter periodontal pathogens, express mostly TLRs. The bacterial activation of TLR-2 and TLR-4 in oral tissue may trigger multiple signalling pathways and the synthesis of inflammatory cytokines and chemokines that promote destruction of the periodontal tissue (11, 12) . This highlights the importance of monitoring these immunocompounds in dental caries development (13, 14) .
The prevalence of dental caries in European adults has been on a steady rise, urging for better dental caries prevention strategies (12) . Saliva is essential for caries prevention, as it clears the bacterial substrate from dental plaque (15, 16) , and if salivation is low due to a variety of reasons, caries risk increases (17) . Saliva production can be reduced by medical treatment (xerogenic drugs), some autoimmune diseases (Sjögren's syndrome, systemic lupus erythematosus), dehydration, or head and neck irradiation (18, 19) . Other factors which influence salivary flow rate include age, sex, circadian rhythm, gum chewing, and saliva collection methods (16, 19) .
However, not only salivary flow or volume can predict the risk of caries, but also its immunity markers. The problem is, however, that the methods of saliva collection are not standardised (20) (21) (22) , which may affect findings and interpretation. Recently, sCD14 was proposed as a salivary marker of inflammation in early childhood caries (23) . To the best of our knowledge, there are no validated and commercially available enzyme-linked immunosorbent assays (ELISA) to quantify sCD14 in human saliva. Furthermore, salivary sCD14 in adults with dental caries has poorly been investigated.
The aim of our study was therefore to fill these gaps by 1) adopting and validating an ELISA to quantify sCD14 concentrations in saliva, 2) comparing salivary sCD14 concentrations under the resting (unstimulated) and stimulated conditions, and 3) determining salivary flow rates and sCD14 secretion rates in dental caries-active and caries-free participants.
PARTICIPANTS AND METHODS

Participants
The study was conducted in Zagreb, Croatia in 2014 and included 30 dental caries-active and 25 caries-free controls. All had signed an informed consent prior to enrolment and the study was approved by the ethics committee of the Zagreb University School of Dental Medicine. The exclusion criteria were deep periodontal pockets, acute or chronic inflammation/infection (oral or systemic), malignancy, diabetes mellitus, pregnancy, or antibiotic therapy. Table 1 shows the demographic, lifestyle, and medical information of the enrolled participants.
Sample size estimation
The sample size was calculated based on the sCD14 concentration as the main outcome measure. All of the calculations were based on the two-tailed Mann-Whitney U test, assuming the significance level of 0.05 and statistical power of 0.8. Based on literature data for resting salivary sCD14 concentrations of healthy subjects (mean=6.57 ng mL -1 , SD=3.70) (10), the sample size sufficient to detect a meaningful sCD14 increase of at least 50 % in the cariesactive group was calculated to be 22 per group. This sample size was also sufficient for stimulated salivary sCD14 (based on the estimates in the caries-free group, since there was no other literature available). Our sample size (30 in the caries-active and 25 in the caries-free group) was therefore sufficient to test the hypothesis that sCD14 concentrations would vary between these groups. All of the power calculations were performed with the G*Power Program, version 3.1.9.2 (University of Düsseldorf, Düsseldorf, Germany) (24) .
Dental examination
All participants were examined by an experienced dentist for cavities (as the defining distinction between the groups) and clinical symptoms associated with caries: gingival bleeding, dryness of mouth, and the burning mouth syndrome. The DMFT index was expressed as the sum of the number of decayed (D), missing (M), and filled (F) teeth according to the criteria defined by the World Health Organization (25) . To test the reproducibility and agreement between the scores, ten participants were examined for tooth decay on two separate occasions. The intra-examiner reliability had a kappa of 0.857, which indicates a very high level of agreement.
Saliva collection
We collected 55 resting and 55 stimulated saliva samples between 8-11 am and 2-4 pm. Two hours before collection, the participants were asked to refrain from eating, drinking, smoking, and brushing teeth to obtain a relatively constant baseline. The resting saliva was collected before the stimulated one using the passive drool method as described earlier (21) . The salivary flow rate (mL min -1 ) was calculated from the saliva volume collected over that one minute and divided in three categories: very low (<0.1 mL min -1 , as a diagnostic criterion for hyposalivation), low (0.1-0.2 mL min -1 ), and normal (>0.2 mL min -1 ) (19). To stimulate salivation, the participants were asked to chew 1.5 g of pure paraffin wax (Parafilm ® , American National Can, Greenwich, CT, USA) for five minutes without swallowing. The volume of stimulated saliva was then measured as described for the unstimulated saliva above and the flow rate calculated. The obtained flow rates were divided in three categories: very low (<0.7 mL min -1 , as diagnostic criterion for hyposalivation), low (0.7-1.0 mL min -1 ), and normal (>1.0 mL min -1 ) (26, 27) . Salivary sCD14 secretion rates (ng min -1 ) were calculated from the saliva volume (mL) in one minute and the corresponding sCD14 concentration (ng mL -1 ). All saliva samples were collected into sterile plastic tubes, and the tubes were capped and immediately stored at -20 °C until analysis.
Determination of sCD14 concentration
The concentrations of sCD14 were determined in salivary supernatants, obtained by centrifuging the thawed saliva samples at 1800 g for 10 min. All supernatants were diluted 10 times with assay dilution buffer before analysis. The 1:10 dilution gave the best signal-to noise ratio in the pre-validation study (results not shown). To eliminate any matrix effects, the standards were prepared by mixing pooled saliva (9 mL; n=5) of the caries-free subjects and the immunoassay buffer (1 mL). Quality controls were prepared in a similar manner by diluting the reference sample in 90 % saliva. The concentrations of sCD14 were determined with the enzyme-linked immunosorbent assay (ELISA) using the commercial Enzo Life Science kit (Farmingdale, NY, USA; catalogue No. ALX-850-302-KI01) according to the manufacturer's instructions. Briefly, the 1:10 saliva dilutions, matrix-matched standards, and the reference sample were captured on the solid phase by the POD-labelled monoclonal antibody specific to human sCD14. Five standards (3.12-50 ng mL -1 ) were used to generate the standard curve. When the antibody reacted with the substrate tetramethyl benzidine (TMB), we added a stop reagent to stop the reaction. The optical absorbance of each well was read at 450 nm using a Personal Lab plate reader (IASON, Graz Austria). Salivary sCD14 concentrations were calculated using linear regression analysis, multiplied by the dilution factor (10), and expressed in ng mL -1 . All samples were analysed in duplicate within three months of collection.
Validation of the salivary sCD14 assay
The assay was validated for both the resting and stimulated saliva. Validation included the determination of the detection limit (LOD), intra-and inter-assay coefficient of variation (CV), and recovery in pooled saliva of five healthy subjects. The LOD was calculated as B+3SD, where B is the mean of 10 blank measurements, and SD is the standard deviation of these measurements. To determine intra-assay variation, we analysed one pooled saliva sample 10 times in a single run and calculated the mean, standard deviation, and coefficient of variation. Inter-assay variation was calculated based on these 10 measurements of the pooled sample over five days. Recovery was calculated by standard addition of pool saliva spiked with commercial sCD14.
The intra-assay variations for the resting and stimulated salivary sCD14 were 5.9 and 8.3 %, respectively. The interassay CVs were 11.6 and 8.9 %, respectively. Mean LOD was 4.9 ng mL -1 and mean recovery 86.5 %.
Statistical analysis
The clinical data were tested for normality of distribution with the Shapiro-Wilk W test. Non-normally distributed variables were compared with the Mann-Whitney U test, and the sCD14 concentration and secretion rate data obtained from the two collection methods were compared with the Wilcoxon matched-pairs signed-rank test. The differences between the variables were tested with the chisquare and Fisher's exact tests.
The associations between the resting and stimulated salivary sCD14 and between sCD14 concentration and salivary flow rates were tested with the Spearman's rank correlation coefficient. We considered statistical significance for all tests at P<0.05. All of the statistical analyses were performed using Dell Statistica, version 13 (Dell Inc., Tulsa, TX, USA). Table 1 summarises and compares the demographic data, clinical symptoms, and some lifestyle characteristics between the participants with active caries and caries-free controls. There were no significant differences in the sex ratios, smoking, use of medicines, clinical symptoms of caries, or the DMFT index.
RESULTS
Salivary sCD14 concentrations
The caries-active group had significantly higher sCD14 concentrations both in the resting (P=0.004) and stimulated saliva (P=0.001) (Figure 1 ). Furthermore, sCD14 levels differed significantly between the resting and stimulated saliva samples in the caries-free controls but not in cariesactive group (P=0.990).
Resting saliva sCD14 significantly correlated with the stimulated saliva values (r=0.631, P<0.05).
Salivary flow rates
The caries-active group showed significantly lower resting salivary flow than controls (0.61±0.42 vs. 0.98±0.52 mL min -1 ; P<0.01). Low salivation (<0.2 mL min -1 ) was found in 26 % of caries-active and 8 % of caries-free participants, and hyposalivation (<0.1 mL min -1 ) was established only in the dental caries subjects (13 %) (P<0.05).
Stimulated salivary flow rates, however, did not differ significantly between the groups (1.33±0.66 mL min -1 in the caries-active vs. 1.54±0.63 mL min -1 in the caries-free group; P=0.253). Twenty percent in the caries-active and 8 % in the control group had low salivary flow rate (<1.0 mL min -1 ). As with the resting saliva, hyposalivation 
Correlation between sCD14 and salivary flow rate
We also observed a weak negative correlation between sCD14 levels and salivary flow rates in caries-active subjects, irrespective of the collection method (r=-0.0896 to -0.1364; P>0.05).
Salivary sCD14 secretion rates
The two groups did not differ in the median resting salivary sCD14 secretion rates (P=0.168), but the cariesactive group had significantly higher sCD14 secretion in the stimulated samples (P<0.01) (Figure 2 ). It also had significantly higher sCD14 secretion rates in the stimulated than the resting saliva (P<0.01).
DISCUSSION
Our findings have confirmed the hypothesis that sCD14 would be higher in caries-active than caries-free participants, and may suggest that the presence of dental caries is an important factor associated with salivary sCD14 levels. To the best of our knowledge, these are the first findings in adults, as earlier studies were focused on children (12, 23) . Except in saliva, elevated sCD14 levels were reported in the serum of patients with chronic periodontitis (28, 29) .
This brings us to another novelty of our research. Salivary immunoassays are often performed with the commercial kits designed for serum analysis. To the best of our knowledge, we have been the first to validate the ELISA for salivary sCD14 following the general recommendations by Jaedicke et al. (30) for validating ELISAs for the use with human saliva samples. Compared to serum analysis, our salivary sCD14 concentrations were approximately 20 times lower. However, the commercial ELISA was highly sensitive, and with slight modifications it was able to detect sCD14 in saliva. Similarly, Browne et al. (31) managed to repurpose some commercial immunoassays for the detection of several cytokines and chemokines in serum for their accurate quantification in saliva.
Our study has also confirmed the association between chronically low salivary flow rate and dental caries (32, 33) .The prevalence of low salivary flow was 20-26 % (depending on the collection method) in the caries-active group and 8 % in the controls. In other words, the risk of caries was about three times higher irrespective of the saliva collection method. Furthermore, hyposalivation was observed only in the caries-active group (10-13 % prevalence, depending on the saliva collection method). The prevalence of hyposalivation in the general population adults is high (10.9-17.8 % in the resting and 0-5.5 % in stimulated saliva) (34) , which may give the reader an idea of the possible risk of caries in the general population.
We observed two interesting findings related to the salivary sCD14 secretion rates. They did not differ between the resting and stimulated saliva in controls (P=0.168) but soared significantly with stimulation in the caries-active group (P<0.01) (Figure 2 ). Does stimulation, therefore, set in motion mechanisms that mobilise pooled sCD14 and therefore reflect more truthfully the existing inflammation? This question remains to be answered in future studies. Another issue that needs addressing is the lack of a standardised procedure for routine saliva analysis in a clinical laboratory (32, 35) .
In conclusion, our findings highlight the diagnostic potential of saliva. We have demonstrated that matrixmatched immunoassay for sCD14 quantification produced an acceptable analytical performance. Salivary sCD14 concentrations were significantly higher in the caries-active group than controls in both resting and stimulated saliva. Dental carries seems to affect both the salivary flow rate and salivary secretion rate. Future research should confirm the role of sCD14 in dental caries development and focus on its clinical application as a predictor of future caries events.
